XML 46 R32.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation Expense Recorded in Statements of Operations The Company recorded stock-based compensation expense in the following expense categories in its accompanying statements of operations:

 

 

 

Year Ended
December 31,

 

(in thousands)

 

2024

 

 

2023

 

Research and development

 

$

12,134

 

 

$

12,626

 

General and administrative

 

 

9,211

 

 

 

12,990

 

 

$

21,345

 

 

$

25,616

 

Summary of Stock Option Activity

The following table summarizes stock option activity for the Plan in the years indicated:

 

 

 

Number
of shares

 

 

Weighted
average
exercise price
per share

 

 

Weighted
average
remaining
contractual
term (years)

 

Outstanding at January 1, 2023

 

 

9,390,930

 

 

$

12.08

 

 

 

8.31

 

Granted

 

 

3,238,898

 

 

$

6.68

 

 

 

 

Exercised

 

 

(26,899

)

 

$

1.78

 

 

 

 

Forfeited

 

 

(704,483

)

 

$

12.58

 

 

 

 

Outstanding at December 31, 2023

 

 

11,898,446

 

 

$

10.60

 

 

 

7.77

 

Granted

 

 

3,922,800

 

 

$

4.40

 

 

 

 

Exercised

 

 

(14,955

)

 

$

3.98

 

 

 

 

Forfeited

 

 

(1,593,753

)

 

$

9.09

 

 

 

 

Outstanding at December 31, 2024

 

 

14,212,538

 

 

$

9.07

 

 

 

7.30

 

Exercisable at December 31, 2024

 

 

8,518,940

 

 

$

11.09

 

 

 

6.40

 

Summary of Information about Stock Options Outstanding and Exercisable

The following table summarizes information about stock options outstanding and exercisable at December 31, 2024 under the Plan:

 

 

 

Options Outstanding

 

 

Options Exercisable

 

Range of Exercise Prices

 

Number
Outstanding

 

 

Weighted
Average
Remaining
Contractual Life
(in years)

 

 

Weighted
Average
Exercise
Price

 

 

Number
Exercisable

 

 

Weighted
Average
Exercise
Price

 

$0.31 - $4.56

 

 

2,991,916

 

 

 

6.29

 

 

$

2.44

 

 

 

2,051,205

 

 

$

1.91

 

$4.57 - $5.43

 

 

3,741,327

 

 

 

8.65

 

 

 

4.69

 

 

 

841,091

 

 

 

4.89

 

$5.44 - $11.72

 

 

4,088,593

 

 

 

7.82

 

 

 

7.86

 

 

 

2,404,123

 

 

 

8.13

 

$11.73 - $88.98

 

 

3,390,702

 

 

 

6.09

 

 

 

21.20

 

 

 

3,222,521

 

 

 

20.75

 

 

 

14,212,538

 

 

 

 

 

 

 

 

 

8,518,940

 

 

 

 

Schedule of Fair Value of Each Option Estimated on Date of Grant Using Weighted Average Assumptions

The fair value of each option was estimated on the date of grant using the weighted average assumptions in the table below:

 

 

 

Year Ended
December 31,

 

 

 

2024

 

 

2023

 

Expected volatility

 

 

84.96

%

 

 

83.57

%

Risk-free interest rate

 

 

4.19

%

 

 

3.82

%

Expected life (in years)

 

 

6.05

 

 

 

6.02

 

Expected dividend yield

 

 

 

 

 

 

Summary of Activity related to RSA Stock-Based Payment Awards

The following table summarizes activity related to RSA stock-based payment awards:

 

 

 

Number of
shares

 

 

Weighted-
average
grant date
fair value

 

Unvested balance at January 1, 2023

 

 

201,716

 

 

$

2.81

 

Vested

 

 

(174,708

)

 

$

2.74

 

Unvested balance at December 31, 2023

 

 

27,008

 

 

$

3.26

 

Vested

 

 

(27,008

)

 

$

3.26

 

Unvested balance at December 31, 2024

 

 

 

 

$

 

Summary of Activity related to RSU Stock-Based Payment Awards

The following table summarizes activity related to RSU stock-based payment awards:

 

 

Number of
shares

 

 

Weighted-
average
grant date
fair value

 

Outstanding at January 1, 2023

 

 

165,000

 

 

$

6.08

 

Vested

 

 

(61,250

)

 

$

5.96

 

Outstanding at December 31, 2023

 

 

103,750

 

 

$

6.16

 

Vested

 

 

(42,500

)

 

$

6.44

 

Forfeited

 

 

(5,000

)

 

$

18.32

 

Outstanding at December 31, 2024

 

 

56,250

 

 

$

4.86